Surrogacy Market Size By Type, By Technology (Intrauterine Insemination, In-vitro Fertilization ), By Age Group, By Service Provider, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023

Description

List of Tables

The global surrogacy market is slated to grow substantially through 2032 owing to the rising consumption of unhealthy food and adoption of a sedentary lifestyle which in turn leads to hormonal changes.

New technology developments, partnerships, and collaborations among the key market players are likely to promote industry expansion in the surrogacy market. For instance, in February 2022, Eqova Healthcare, a significant company in East Delhi that provides a number of medical services, was purchased by Max Healthcare. Through this acquisition, Max Healthcare will be able to provide the residents of East Delhi with high-quality healthcare while strengthening its network presence in a wide area.

The surrogacy market has been divided in terms of type, technology, age group, service provider, and region.

Based on type, the gestational surrogacy segment recorded the largest revenue in 2022 worth over $13 billion and is expected to showcase steady growth till 2032 since the majority of consumers use gestational techniques to avoid legal entanglements, which will encourage their use through the analysis timeline.

With respect to the age group, the below 35 years segment is set to witness considerable growth through the review years attributed to the fact that most surrogate mothers are under the age of 35, owing to the high treatment success rate in this age range.

On the other hand, the 38-39 years segment is speculated to propel significantly over the forthcoming timeframe fueled by the age group's fertility rate declines because of lifestyle modifications and the usage of birth control to address certain conditions. Thereby, the rising number of women preferring surrogacy technology is likely to boost market growth during the forecast timeframe. In contrast, the over 44 years segment is set to amass over $700 million market valuation by 2032 driven by the high rates of infertility among this age range. Additionally, this age group's rapid adoption of cutting-edge prenatal technology will create the potential for segmental growth.

From the regional front, the North America surrogacy market registered more than 22% revenue share in 2022 and is estimated to proliferate steadily through the analysis timeline boosted by rising healthcare costs and rising government attempts to raise public awareness of infertility and its implications. Additionally, as infertility rates rise in the US, more people will turn to surrogacy in the years to come.

Meanwhile, the Africa surrogacy industry is poised to witness approximately 26% CAGR from 2023 to 2032 credited to the population's growing awareness of infertility treatments and growing health concerns in the region.

Product Code: 4469

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Base estimates and working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Surrogacy industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Type trends
- 2.1.3 Technology trends
- 2.1.4 Age group trends
- 2.1.5 Service provider trends
- 2.1.6 Regional trends

Chapter 3 Surrogacy Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing number of infertility cases
  - 3.3.1.2 Rising awareness about the infertility treatment options available in the market
  - 3.3.1.3 Increasing adoption of sedentary lifestyle and unhealthy eating habits leading to hormonal changes
  - 3.3.1.4 Increasing number of fertility clinics
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Stringent regulations pertaining commercial surrogacy
  - 3.3.2.2 High cost involved in surrogacy procedure
3.4 Growth potential analysis
- 3.4.1 By type
- 3.4.2 By technology
- 3.4.3 By age group
- 3.4.4 By service provider
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Porter's analysis
- 3.7.1 Bargaining power of suppliers
- 3.7.2 Bargaining power of buyers
- 3.7.3 Threat of new entrants
- 3.7.4 Threat of substitutes
- 3.7.5 Industry rivalry
3.8 PESTEL analysis
- 3.8.1 Political
- 3.8.2 Economic
- 3.8.3 Social
- 3.8.4 Tecnhological
- 3.8.5 Environmental
- 3.8.6 Legal

Chapter 4 Competitive Landscape, 2021

4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard, 2021

Chapter 5 Surrogacy Market, By Type

5.1 Key segment trends
5.2 Gestational surrogacy
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Traditional surrogacy
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Surrogacy Market, By Technology

6.1 Key segment trends
6.2 Intrauterine insemination (IUI)
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 In-vitro fertilization (IVF)
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.2 Classical/standard IVF
  - 6.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.3 Intracytoplasmic sperm injection (ICSI)
  - 6.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Others
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Surrogacy Market, By Age Group

7.1 Key segment trends
7.2 Below 35 years
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 35-37 years
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 38-39 years
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 40-42 years
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 43-44 years
- 7.6.1 Market size, by region, 2018 - 2032 (USD Million)
7.7 Over 44 years
- 7.7.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Surrogacy Market, By Service Provider

8.1 Key segment trends
8.2 Hospitals
- 8.2.1 Market size, by region, 2018 - 2032 (USD Million)
8.3 Fertility clinics
- 8.3.1 Market size, by region, 2018 - 2032 (USD Million)
8.4 Others
- 8.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 9 Surrogacy Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 Market size, by country, 2018 - 2032 (USD Million)
- 9.2.2 Market size, by type, 2018 - 2032 (USD Million)
- 9.2.3 Market size, by technology, 2018 - 2032 (USD Million)
  - 9.2.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
- 9.2.4 Market size, by age group, 2018 - 2032 (USD Million)
- 9.2.5 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.2.6 U.S.
  - 9.2.6.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.2.6.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.2.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.2.6.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.2.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3 Europe
- 9.3.1 Market size, by country, 2018 - 2032 (USD Million)
- 9.3.2 Market size, by type, 2018 - 2032 (USD Million)
- 9.3.3 Market size, by technology, 2018 - 2032 (USD Million)
  - 9.3.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
- 9.3.4 Market size, by age group, 2018 - 2032 (USD Million)
- 9.3.5 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.6 Czech Republic
  - 9.3.6.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.6.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.6.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.7 Estonia
  - 9.3.7.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.7.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.7.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.7.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.7.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.8 Georgia
  - 9.3.8.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.8.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.8.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.8.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.8.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.9 Greece
  - 9.3.9.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.9.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.9.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.9.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.9.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.10 Poland
  - 9.3.10.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.10.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.10.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.10.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.10.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.11 Sweden
  - 9.3.11.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.11.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.11.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.11.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.11.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.3.12 UK
  - 9.3.12.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.3.12.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.3.12.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.3.12.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.3.12.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.4 Asia Pacific
- 9.4.1 Market size, by country, 2018 - 2032 (USD Million)
- 9.4.2 Market size, by type, 2018 - 2032 (USD Million)
- 9.4.3 Market size, by technology, 2018 - 2032 (USD Million)
  - 9.4.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
- 9.4.4 Market size, by age group, 2018 - 2032 (USD Million)
- 9.4.5 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.4.6 India
  - 9.4.6.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.4.6.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.4.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.4.6.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.4.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.4.7 Thailand
  - 9.4.7.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.4.7.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.4.7.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.4.7.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.4.7.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.4.8 South Korea
  - 9.4.8.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.4.8.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.4.8.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.4.8.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.4.8.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.5 Africa
- 9.5.1 Market size, by country, 2018 - 2032 (USD Million)
- 9.5.2 Market size, by type, 2018 - 2032 (USD Million)
- 9.5.3 Market size, by technology, 2018 - 2032 (USD Million)
  - 9.5.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
- 9.5.4 Market size, by age group, 2018 - 2032 (USD Million)
- 9.5.5 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.5.6 Kenya
  - 9.5.6.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.5.6.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.5.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.5.6.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.5.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.5.7 Nigeria
  - 9.5.7.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.5.7.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.5.7.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.5.7.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.5.7.4 Market size, by service provider, 2018 - 2032 (USD Million)
- 9.5.8 South Africa
  - 9.5.8.1 Market size, by type, 2018 - 2032 (USD Million)
  - 9.5.8.2 Market size, by technology, 2018 - 2032 (USD Million)
    - 9.5.8.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
  - 9.5.8.3 Market size, by age group, 2018 - 2032 (USD Million)
  - 9.5.8.4 Market size, by service provider, 2018 - 2032 (USD Million)

Chapter 10 Company Profiles

10.1 IVIRMA
- 10.1.1 Business overview
- 10.1.2 Financial data
- 10.1.3 Service landscape
- 10.1.4 Strategic outlook
- 10.1.5 SWOT analysis
10.2 Boston IVF
- 10.2.1 Business overview
- 10.2.2 Financial data
- 10.2.3 Service landscape
- 10.2.4 Strategic outlook
- 10.2.5 SWOT analysis
10.3 Ovation Fertility
- 10.3.1 Business overview
- 10.3.2 Financial data
- 10.3.3 Service landscape
- 10.3.4 Strategic outlook
- 10.3.5 SWOT analysis
10.4 Extraordinary Conceptions
- 10.4.1 Business overview
- 10.4.2 Financial data
- 10.4.3 Service landscape
- 10.4.4 Strategic outlook
- 10.4.5 SWOT analysis
10.5 Circle Surrogacy
- 10.5.1 Business overview
- 10.5.2 Financial data
- 10.5.3 Service landscape
- 10.5.4 Strategic outlook
- 10.5.5 SWOT analysis
10.6 Growing Generations
- 10.6.1 Business overview
- 10.6.2 Financial data
- 10.6.3 Service landscape
- 10.6.4 Strategic outlook
- 10.6.5 SWOT analysis
10.7 New Hope Fertility Clinic
- 10.7.1 Business overview
- 10.7.2 Financial data
- 10.7.3 Service landscape
- 10.7.4 Strategic outlook
- 10.7.5 SWOT analysis
10.8 Bourn Hall International (TVM Capital Healthcare)
- 10.8.1 Business overview
- 10.8.2 Financial data
- 10.8.3 Service landscape
- 10.8.4 Strategic outlook
- 10.8.5 SWOT analysis
10.9 NOVA IVF
- 10.9.1 Business overview
- 10.9.2 Financial data
- 10.9.3 Service landscape
- 10.9.4 Strategic outlook
- 10.9.5 SWOT analysis
10.10 MLSPL (Morpheus IVF Clinic)
- 10.10.1 Business overview
- 10.10.2 Financial data
- 10.10.3 Service landscape
- 10.10.4 Strategic outlook
- 10.10.5 SWOT analysis
10.11 Max Healthcare
- 10.11.1 Business overview
- 10.11.2 Financial data
- 10.11.3 Service landscape
- 10.11.4 Strategic outlook
- 10.11.5 SWOT analysis
10.12 Scanfert Clinic
- 10.12.1 Business overview
- 10.12.2 Financial data
- 10.12.3 Service landscape
- 10.12.4 Strategic outlook
- 10.12.5 SWOT analysis
10.13 Bangkok IVF Center
- 10.13.1 Business overview
- 10.13.2 Financial data
- 10.13.3 Service landscape
- 10.13.4 Strategic outlook
- 10.13.5 SWOT analysis
10.14 Houston Fertility Center
- 10.14.1 Business overview
- 10.14.2 Financial data
- 10.14.3 Service landscape
- 10.14.4 Strategic outlook
- 10.14.5 SWOT analysis